Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Receivables - Net (2016 - 2023)

Historic Receivables - Net for Palisade Bio (PALI) over the last 12 years, with Q1 2023 value amounting to $300000.0.

  • Palisade Bio's Receivables - Net changed N/A to $300000.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $300000.0, marking a year-over-year change of. This contributed to the annual value of $59000.0 for FY2020, which is 18009.87% up from last year.
  • Per Palisade Bio's latest filing, its Receivables - Net stood at $300000.0 for Q1 2023.
  • In the past 5 years, Palisade Bio's Receivables - Net registered a high of $300000.0 during Q1 2023, and its lowest value of $8779.0 during Q3 2020.
  • For the 4-year period, Palisade Bio's Receivables - Net averaged around $88899.5, with its median value being $59000.0 (2020).
  • Per our database at Business Quant, Palisade Bio's Receivables - Net tumbled by 9283.68% in 2019 and then soared by 24832.92% in 2021.
  • Over the past 4 years, Palisade Bio's Receivables - Net (Quarter) stood at $21064.0 in 2019, then soared by 180.1% to $59000.0 in 2020, then changed by 0.0% to $59000.0 in 2021, then skyrocketed by 408.47% to $300000.0 in 2023.
  • Its last three reported values are $300000.0 in Q1 2023, $59000.0 for Q2 2021, and $25259.0 during Q1 2021.